Jennifer Good | executive |
Lisa Delfini | executive |
Leland Gershell | analyst |
David Clark | executive |
Annabel Samimy | analyst |
Mayank Mamtani | analyst |
Good afternoon, and welcome to the Trevi Therapeutics First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. Various remarks that management makes during this conference call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent quarterly report on Form 10-Q, which the company filed with the SEC this afternoon.
In addition, any forward-looking statements represent the company's views only as of today and should not be relied upon as representing the company's views at any subsequent date.